BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37602319)

  • 1. Role of miR-301b-3p/5p in breast cancer: A study based on the cancer GenomeAtlas program (TCGA) and bioinformatics analysis.
    Zhou Q; Wang F; Sun E; Liu X; Lu C
    Noncoding RNA Res; 2023 Dec; 8(4):571-578. PubMed ID: 37602319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-301b-3p Regulates Breast Cancer Cell Proliferation, Migration, and Invasion by Targeting NR3C2.
    Fan Y; Li Y; Zhu Y; Dai G; Wu D; Gao Z; Zhang L; Xu D
    J Oncol; 2021; 2021():8810517. PubMed ID: 33542733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
    Dong X; Chang M; Song X; Ding S; Xie L; Song X
    Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
    Lu X; Duan J; Zhou R; Xu Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):35-44. PubMed ID: 34369713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-301b-3p can be used as a Potential Marker for the Diagnosis of Lung Adenocarcinoma.
    Qi W; Niu N; Zhao J; Liu H; Yang F
    Comb Chem High Throughput Screen; 2024; 27(8):1131-1139. PubMed ID: 37605415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS9-AS1 Constrains Breast Cancer Cell Invasion and Proliferation via Sequestering miR-301b-3p.
    Chen J; Cheng L; Zou W; Wang R; Wang X; Chen Z
    Front Cell Dev Biol; 2021; 9():719993. PubMed ID: 34900984
    [No Abstract]   [Full Text] [Related]  

  • 7. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
    Kunc M; Popęda M; Niemira M; Szałkowska A; Bieńkowski M; Pęksa R; Łacko A; Radecka BS; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Iżycka-Świeszewska E; Krętowski A; Żaczek AJ; Biernat W; Senkus-Konefka E
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer.
    Fort RS; Mathó C; Oliveira-Rizzo C; Garat B; Sotelo-Silveira JR; Duhagon MA
    Exp Hematol Oncol; 2018; 7():10. PubMed ID: 29744254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-301b-3p accelerates the growth of gastric cancer cells by targeting zinc finger and BTB domain containing 4.
    Fan H; Jin X; Liao C; Qiao L; Zhao W
    Pathol Res Pract; 2019 Nov; 215(11):152667. PubMed ID: 31585814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and potential mechanisms of
    Zhao L; Tian C; Xiao E; Du J; Liang J; Chen X; Chi W
    Open Med (Wars); 2020; 15(1):728-738. PubMed ID: 33336030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microrna Expression Profiling of Macrophage Line Raw264.7 Infected by Candida Albicans.
    Wu CX; Cheng J; Wang YY; Wang JJ; Guo H; Sun H
    Shock; 2017 Apr; 47(4):520-530. PubMed ID: 27749761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
    Zheng H; Bai L
    Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
    Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCSK9i promoting the transformation of AS plaques into a stable plaque by targeting the miR-186-5p/Wipf2 and miR-375-3p/Pdk1/Yap1 in ApoE-/- mice.
    Zhao Y; Liu N; Zhang J; Zhao L
    Front Med (Lausanne); 2024; 11():1284199. PubMed ID: 38596793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
    Yang X; Pang YY; He RQ; Lin P; Cen JM; Yang H; Ma J; Chen G
    FEBS Open Bio; 2018 Jan; 8(1):64-84. PubMed ID: 29321958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.